In order to validate the findings from the fibroblast cells, we also examined the effect of melatonin treatment in human neuroblastoma SH-SY5Y cells, demonstrating that melatonin could increase the expression of Sox2 (Figure 6A) significantly in a concentration-dependent manner. The gene discussed is SOX2; the disease is neuroblastoma.